Suppr超能文献

细胞穿透肽利用了多配体聚糖。

Cell-penetrating peptide exploited syndecans.

作者信息

Letoha Tamás, Keller-Pintér Anikó, Kusz Erzsébet, Kolozsi Csongor, Bozsó Zsolt, Tóth Gábor, Vizler Csaba, Oláh Zoltán, Szilák László

机构信息

Biological Research Center of the Hungarian Academy of Sciences, H-6726 Szeged, Hungary.

出版信息

Biochim Biophys Acta. 2010 Dec;1798(12):2258-65. doi: 10.1016/j.bbamem.2010.01.022. Epub 2010 Feb 2.

Abstract

Cell-penetrating peptides (CPPs) are short peptides capable of translocating across the plasma membrane of live cells and transporting conjugated compounds intracellularly. Fifteen years after discovering the first model cationic CPPs, penetratin and TAT, CPP internalization is still challenging many questions. Particularly it has been unknown whether CPPs enter the cells with or without mediation of a specific surface receptor. Here we report that syndecan-4, the universally expressed isoform of the syndecan family of transmembrane proteoglycans, binds and mediates transport of the three most frequently utilized cationic CPPs (penetratin, octaarginine and TAT) into the cells. Quantitative uptake studies and mutational analyses demonstrate that attachment of the cationic CPPs is mediated by specific interactions between the heparan sulfate chains of syndecan-4 and the CPPs. Protein kinase C alpha is also heavily involved in the uptake mechanism. The collected data give the first direct evidence on the receptor-mediated uptake of cationic CPPs and may replace the long-thought, but already contradicted membrane penetration hypothesis. Thus our study might give an answer for a decade long debate and foster the development of rationalized, syndecan-4 targeted novel delivery technologies.

摘要

细胞穿透肽(CPPs)是一类短肽,能够穿过活细胞的质膜并将共轭化合物转运到细胞内。在发现首个模型阳离子CPPs(穿膜肽和TAT)15年后,CPPs的内化作用仍存在许多有待解决的问题。特别是,目前尚不清楚CPPs进入细胞是否需要特定表面受体的介导。在此,我们报告跨膜蛋白聚糖syndecan家族普遍表达的异构体syndecan-4,能结合三种最常用的阳离子CPPs(穿膜肽、八聚精氨酸和TAT)并介导它们进入细胞。定量摄取研究和突变分析表明,阳离子CPPs的附着是由syndecan-4的硫酸乙酰肝素链与CPPs之间的特异性相互作用介导的。蛋白激酶Cα也在摄取机制中发挥重要作用。所收集的数据首次直接证明了阳离子CPPs的受体介导摄取,可能会取代长期以来虽被认可但已遭反驳的膜渗透假说。因此,我们的研究可能为长达十年的争论提供答案,并推动基于syndecan-4的合理新型递送技术的发展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验